Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.57 USD | -11.49% |
|
-16.16% | -44.12% |
Business Summary
Number of employees: 6
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Biopharmaceuticals
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | +144.15% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | +144.15% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Founder | 67 | 01/05/01 | |
Jonathan Kaufman
CEO | Chief Executive Officer | 58 | 01/05/01 |
Douglas Johnston
DFI | Director of Finance/CFO | 40 | 01/21/01 |
Janet Okonski
CTO | Chief Tech/Sci/R&D Officer | - | 01/21/01 |
Joseph Janicki
CTO | Chief Tech/Sci/R&D Officer | - | - |
Michelle Gruber
COO | Chief Operating Officer | - | 01/09/01 |
Katie Johnston
AUD | Comptroller/Controller/Auditor | - | - |
Allison Houck
PRN | Corporate Officer/Principal | - | - |
Tomohiro Ueda
PRN | Corporate Officer/Principal | - | - |
Robert Moldwin
PRN | Corporate Officer/Principal | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Jonathan Kaufman
CEO | Chief Executive Officer | 58 | 01/05/01 |
Founder | 67 | 01/05/01 | |
Byong Kim
BRD | Director/Board Member | 54 | 01/22/01 |
Ryan Pruchnic
BRD | Director/Board Member | 50 | 01/21/01 |
Naoki Yoshimura
BRD | Director/Board Member | 67 | 01/21/01 |
Daniel Cohen
BRD | Director/Board Member | 60 | 21/23/21 |
Lori Birder
BRD | Director/Board Member | 64 | 17/23/17 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 7,605,636 | 4,520,361 ( 59.43 %) | 0 | 59.43 % |
Company contact information
Lipella Pharmaceuticals, Inc.
7800 Susquehanna Street Suite 505
15208, Pittsburgh
+412-901-0315
http://www.lipella.com![address Lipella Pharmaceuticals Inc.(LIPO)](https://cdn.zonebourse.com/static/address/148356418.png)
Sector
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-44.12% | 4.34M | |
+15.19% | 121B | |
+19.91% | 114B | |
-19.80% | 20.43B | |
-16.19% | 16.55B | |
-13.45% | 16.45B | |
-44.35% | 15.59B | |
+66.67% | 15.19B | |
+2.13% | 13.54B | |
+119.39% | 10.96B |
- Stock Market
- Equities
- LIPO Stock
- Company Lipella Pharmaceuticals Inc.